Outpatient Embedded Palliative Care for Patients with Advanced Thoracic Malignancy: A Retrospective Cohort Study
-
Published:2024-03-07
Issue:3
Volume:31
Page:1389-1399
-
ISSN:1718-7729
-
Container-title:Current Oncology
-
language:en
-
Short-container-title:Current Oncology
Author:
Boulanger Mary C.12ORCID, Krasne Margaret D.3, Gough Ethan K.4, Myers Samantha1, Browner Ilene S.13, Feliciano Josephine L.15
Affiliation:
1. Department of Medical Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD 21287, USA 2. Department of Medical Oncology, Dana-Farber Cancer Institute/Massachusetts General Brigham, Boston, MA 02114, USA 3. Department of Internal Medicine, Johns Hopkins Hospital, Baltimore, MD 21287, USA 4. Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA 5. Johns Hopkins Bayview, 301 Lord Mason Drive, Baltimore, MD 21224, USA
Abstract
Although cancer care is often contextualized in terms of survival, there are other important cancer care outcomes, such as quality of life and cost of care. The ASCO Value Framework assesses the value of cancer therapies not only in terms of survival but also with consideration of quality of life and financial cost. Early palliative care for patients with advanced cancer is associated with improved quality of life, mood, symptoms, and overall survival for patients, as well as cost savings. While palliative care has been shown to have numerous benefits, the impact of real-world implementation of outpatient embedded palliative care on value-based metrics is not fully understood. We sought to describe the association between outpatient embedded palliative care in a multidisciplinary thoracic oncology clinic and inpatient value-based metrics. We performed a retrospective cohort study of 215 patients being treated for advanced thoracic malignancies with non-curative intent. We evaluated the association between outpatient embedded palliative care and inpatient clinical outcomes including emergency room visits, hospitalizations, intensive care unit admissions, hospital charges, as well as hospital quality metrics including 30-day readmissions, admissions within 30 days of death, inpatient mortality, and inpatient hospital charges. Outpatient embedded palliative care was associated with lower hospital charges per day (USD 3807 vs. USD 4695, p = 0.024). Furthermore, patients who received outpatient embedded palliative care had lower hospital admissions within 30 days of death (O.R. 0.45; 95% CI 0.29, 0.68; p < 0.001) and a lower inpatient mortality rate (IRR 0.67; 95% CI 0.48, 0.95; p = 0.024). Our study further supports that outpatient palliative care is a high-value intervention and alternative models of palliative care, including one embedded into a multidisciplinary thoracic oncology clinic, is associated with improved value-based metrics.
Reference30 articles.
1. (2024, January 05). Survelliance, Epidemiology, and End Results Program: Esophagus, Available online: https://seer.cancer.gov/statistics-network/explorer/application.html?site=17&data_type=4&graph_type=6&compareBy=sex&chk_sex_1=1&race=1&age_range=1&stage=106&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2. 2. (2024, January 05). Survelliance, Epidemiology, and End Results Program: Lung and Bronchus, Available online: https://seer.cancer.gov/statistics-network/explorer/application.html?site=47&data_type=4&graph_type=5&compareBy=stage&chk_stage_106=106&series=age_range&chk_age_range_1=1&sex=1&race=1&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2. 3. (2024, January 05). Survelliance, Epidemiology, and End Results Program: Cancer Stat Facts: Lung and Bronchus Cancer, Available online: https://seer.cancer.gov/statfacts/html/lungb.html. 4. Quality of life in NSCLC survivors—A multicenter cross-sectional study;Hechtner;J. Thorac. Oncol.,2019 5. Dalhammar, K., Kristensson, J., Falkenback, D., Rasmussen, B.H., and Malmström, M. (2022). Symptoms, problems and quality of life in patients newly diagnosed with oesophageal and gastric cancer—A comparative study of treatment strategy. BMC Cancer, 22.
|
|